Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
RARE Price/Volume Stats
| Current price | $37.17 | 52-week high | $60.37 |
| Prev. close | $36.91 | 52-week low | $29.59 |
| Day low | $36.50 | Volume | 930,289 |
| Day high | $37.48 | Avg. volume | 912,736 |
| 50-day MA | $35.79 | Dividend yield | N/A |
| 200-day MA | $44.98 | Market Cap | 3.51B |
RARE Stock Price Chart Interactive Chart >
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
RARE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RARE Price Returns
| 1-mo | 11.22% |
| 3-mo | -3.75% |
| 6-mo | -24.73% |
| 1-year | -11.01% |
| 3-year | -30.17% |
| 5-year | -46.84% |
| YTD | -11.65% |
| 2024 | -12.02% |
| 2023 | 3.22% |
| 2022 | -44.90% |
| 2021 | -39.25% |
| 2020 | 224.12% |